What are the stages of CKD?

The Chronic Kidney Disease Solution™ By Shelly Manning It is an eBook that includes the most popular methods to care and manage kidney diseases by following the information provided in it. This easily readable eBook covers up various important topics like what is chronic kidney disease, how it is caused, how it can be diagnosed, tissue damages caused by chronic inflammation, how your condition is affected by gut biome, choices for powerful lifestyle and chronic kidney disease with natural tools etc.

Stages of Chronic Kidney Disease (CKD)

Chronic Kidney Disease (CKD) is classified into five stages based on the estimated glomerular filtration rate (eGFR), which measures how well the kidneys are filtering blood. These stages help healthcare providers determine the severity of the disease, guide treatment, and monitor progression. Here’s a detailed overview of each stage of CKD:

Stage 1: Kidney Damage with Normal or Increased eGFR

eGFR: ≥90 mL/min/1.73 m²

Characteristics:

Kidney Function: Normal or high eGFR indicates that the kidneys are functioning well, but there are signs of kidney damage.
Indicators of Damage: Presence of proteinuria (protein in the urine), hematuria (blood in the urine), structural abnormalities (detected via imaging), or genetic markers of kidney disease.

Symptoms:

Often asymptomatic.
May have signs of the underlying condition causing kidney damage (e.g., hypertension, diabetes).

Management:

Monitor: Regular check-ups and monitoring of kidney function and markers of damage.
Control Underlying Conditions: Manage blood pressure, blood sugar levels, and other contributing factors.
Lifestyle Modifications: Healthy diet, regular exercise, smoking cessation, and avoiding nephrotoxic substances.

Stage 2: Mildly Decreased eGFR

eGFR: 60-89 mL/min/1.73 m²

Characteristics:

Kidney Function: Mild reduction in eGFR, indicating some loss of kidney function.
Indicators of Damage: Continued presence of proteinuria, hematuria, or structural abnormalities.

Symptoms:

Often asymptomatic.
Possible mild symptoms related to underlying conditions.

Management:

Monitor: Regular monitoring of kidney function and damage markers.
Control Underlying Conditions: Aggressive management of hypertension, diabetes, and other contributing factors.
Lifestyle Modifications: Continued focus on healthy lifestyle choices.

Stage 3: Moderately Decreased eGFR

eGFR: 30-59 mL/min/1.73 m²

Characteristics:

Kidney Function: Moderate reduction in eGFR, indicating significant loss of kidney function.
Indicators of Damage: Persistent proteinuria, hematuria, or structural abnormalities.

Symptoms:

Fatigue and weakness.
Fluid retention (edema) in the legs, ankles, feet, or hands.
Changes in urine output and frequency.
Elevated blood pressure.
Possible early symptoms of anemia and bone disease.

Management:

Monitor: More frequent monitoring of kidney function, electrolytes, and damage markers.
Medications: ACE inhibitors or ARBs to manage blood pressure and reduce proteinuria.
Lifestyle Modifications: Continued emphasis on diet, exercise, and avoiding nephrotoxic substances.
Address Complications: Manage anemia, bone disease, and other complications as they arise.

Stage 4: Severely Decreased eGFR

eGFR: 15-29 mL/min/1.73 m²

Characteristics:

Kidney Function: Severe reduction in eGFR, indicating advanced loss of kidney function.
Indicators of Damage: Significant proteinuria, hematuria, or structural abnormalities.

Symptoms:

More pronounced fatigue and weakness.
Swelling and fluid retention.
Shortness of breath.
Changes in urine output and frequency.
Severe anemia and symptoms of bone disease.
Possible nausea and loss of appetite.

Management:

Monitor: Very frequent monitoring of kidney function, electrolytes, and damage markers.
Medications: Intensified use of ACE inhibitors or ARBs, and other medications to manage blood pressure, proteinuria, anemia, and bone disease.
Prepare for Dialysis or Transplant: Discuss and plan for potential dialysis or kidney transplant.
Lifestyle Modifications: Strict adherence to dietary restrictions, including reduced sodium, potassium, and phosphate intake.

Stage 5: End-Stage Renal Disease (ESRD)

eGFR: <15 mL/min/1.73 m²

Characteristics:

Kidney Function: Kidney function is severely impaired and unable to sustain life without treatment.
Indicators of Damage: Severe proteinuria, hematuria, and structural abnormalities.

Symptoms:

Severe fatigue and weakness.
Persistent fluid retention and swelling.
Severe shortness of breath.
Dramatic changes in urine output and frequency.
Nausea, vomiting, and loss of appetite.
Severe anemia and bone disease symptoms.
Possible neurological symptoms such as confusion and difficulty concentrating.

Management:

Dialysis: Initiation of hemodialysis or peritoneal dialysis to remove waste products and excess fluids from the blood.
Kidney Transplant: Consideration for a kidney transplant if the patient is eligible.
Medications: Continued use of medications to manage symptoms and complications.
Lifestyle Modifications: Adherence to a strict diet and fluid restrictions, along with ongoing support and education.

Monitoring and Follow-Up

1. Regular Check-Ups

Frequent assessments of kidney function (eGFR), electrolytes, blood pressure, and other relevant parameters.
Monitoring for complications such as anemia, bone disease, cardiovascular disease, and fluid balance issues.

2. Patient Education

Providing information on managing CKD, including dietary restrictions, medication adherence, and lifestyle changes.
Support groups and resources to help patients cope with the psychological and emotional aspects of CKD.

3. Multidisciplinary Care

Involving nephrologists, dietitians, social workers, and other healthcare professionals in the care plan.
Coordinated care to address all aspects of CKD and improve patient outcomes.

Conclusion

Chronic Kidney Disease (CKD) progresses through five stages based on the estimated glomerular filtration rate (eGFR). Early stages are often asymptomatic and manageable with lifestyle modifications and control of underlying conditions. As CKD advances, symptoms become more pronounced, and more intensive interventions, including medications, dialysis, or kidney transplant, may be required. Regular monitoring, patient education, and multidisciplinary care are essential for managing CKD and improving the quality of life for affected individuals.